Skip to Content

Coronavirus information for Feinberg.

Download the full-sized PDF of Dietary Supplements for ADHD: A Controlled Trial
Download the file

Actions

Download Analytics Citations

Export to: EndNote

Collections

This file is in the following collections:

Pediatric Neurology Briefs: Volume 15, Issue 09

Dietary Supplements for ADHD: A Controlled Trial Open Access (recommended)

Descriptions

Resource type(s)
Article
Keyword
Placebo Group
Attention Deficit/Hyperactivity Disorder
Docosahexaenoic Acid
Rights
Attribution 4.0 International

Creator
Millichap, J. Gordon
Abstract
The effect of docosahexaenoic acid (DHA) supplementation (345 mg/d) on the symptoms of attention deficit/hyperactivity disorder (ADHD) was determined in 63 children, ages 6 to 12 years, at the Mayo Clinic and Baylor College of Medicine, Houston, TX.
Publisher
DigitalHub. Galter Health Sciences Library
Pediatric Neurology Briefs Publishers
Date Created
2001
Original Identifier
PNB-15-70-b
Language
English
Subject: MESH
Infant
Child
Pediatrics
Brain Diseases
Neurology
Child Development
Nervous System Diseases
Neurosurgery
DOI
10.15844/pedneurbriefs-15-9-10

File Details

File Properties
Mime type: application/pdf
File size: 2887.3 kB